South Africa escalates Ozempic crackdown as doctors risk losing licences over copycat weight-loss drugs

South Africa has escalated its crackdown on copycat weight-loss medicines, ordering the recall of compounded versions of Ozempic and Mounjaro while warning doctors, pharmacists and other healthcare professionals that they could face fines, disciplinary action or even lose their licences for prescribing, dispensing or stocking the products.